课题基金 / 基金详情

Geriatric Medication Safety Symposium

Geriatric Medication Safety Symposium
老年用药安全研讨会
批准号:
10456818
负责人:
Rajender R Aparasu
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-01 至 2026-07-31

项目摘要

项目成果

Rajender R Aparasu的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 与药物相关的发病率和死亡率是老年人的一个重要健康问题,他们高度关注 容易受到药物相关问题的影响。安全用药实践需要协调努力 药物使用过程中的提供者和患者。老年人与药物相关的问题包括 开出高风险药物以防止老年人滥用处方药。减少用药 错误和改善用药安全是国家的主要优先事项。因此,我们的目标是举办 老年用药安全研讨会在世界上最大的医疗中心德克萨斯医学中心举行 (TMC),每年传播和实施老年人用药安全的循证方法 成人提高老年护理质量。与休斯敦大学药学院合作 与德克萨斯大学麦戈文医学院合作举办休斯顿用药安全研讨会 过去三年专注于药物安全问题的各个方面,例如高风险药物, 级联处方,并通过国家认可专家的演示进行取消处方。平均 每年有 151 名不同的卫生专业人士参加该研讨会,以丰富他们的实践和研究 用药安全。此外,研讨会还设有研究讲台和海报,这些讲台和海报发表在 同行评审期刊。我们请求五年的资金来举办老年用药安全会议 研讨会将继续我们成功传播有关药物安全问题的成功努力 实践、研究和政策。本次年度研讨会将: (i) 提供出色的跨专业教育 供从业者和研究人员讨论老年人循证用药安全方法的论坛; (ii) 加强患者护理和药物安全研究最佳实践方面的合作; (iii) 传播 通过网络研讨会和出版物获得全国研讨会的知识和研究结果。提案 包括由选定的 TMC 机构代表召开的每月计划委员会会议,以制定计划和 在 TMC 组织为期两天的研讨会,覆盖超过 20,000 名医疗保健专业人员。的 研讨会包括四场全体会议、讲台和海报会议以及实践/研究研讨会, 五年内基于网络的内容交付和虚拟内容集成,以实现更大的覆盖范围。的 即将举行的研讨会的重点领域包括 COVID-19 大流行期间的超说明书用药、药物 负担、更安全的阿片类药物使用、药物不良事件、显着的药物相互作用、过渡期间的药物安全性 住院护理中的护理和用药安全。目标受众包括医生、护士、药剂师、 学生、居民、研究员、研究人员和其他人。除了以下内容之外,还将创建教育和媒体工具 在《社会和行政药学研究》杂志上发表论文集。总体而言,老年病 药物安全研讨会将为患者提供一个独特的跨专业教育和研究论坛 从业人员和研究人员致力于使 TMC 及其他地区的老年人的用药实践更加安全。
英文摘要
ABSTRACT Medication-related morbidity and mortality are a significant health concern in older adults, who are highly susceptible to medication-related problems. Safe medication use practices require coordinated efforts by providers and patients in the medication use process. Medication-related problems in older adults range from prescribing of high-risk medications to misuse of prescribed medications by older adults. Reducing medication errors and improving medication safety are major national priorities. Therefore, our objective is to host the Geriatric Medication Safety Symposium in the largest medical complex in the world, the Texas Medical Center (TMC), annually to disseminate and implement the evidence-based approaches for medication safety in older adults to improve the quality of geriatric care. The University of Houston College of Pharmacy in collaboration with the University of Texas McGovern Medical School organized the Houston Medication Safety Symposium for the past three years focusing on various aspects of medication safety issues such high-risk medications, prescribing cascades, and deprescribing with presentations from nationally recognized experts. An average of 151 diverse health professions participated in the symposium each year to enrich their practice and research on medication safety. In addition, the symposium included research podiums and posters that were published in a peer-reviewed journal. We are requesting five years of funding to host the Geriatric Medication Safety Symposium to continue our successful efforts to disseminate critical medication safety issues with respect to practice, research, and policy. This annual symposium will: (i) Provide an excellent interprofessional educational forum for practitioners and researchers to discuss evidence-based medication safety approaches in older adults; (ii) Increase collaborations for best practices in patient care and medication safety research; and (iii) Disseminate the knowledge and findings from the symposium nationally through webinars and publications. The proposal includes monthly planning committee meetings from representatives of selected TMC institutions to plan and organize the two-day symposium in the TMC, with a reach of over 20,000 healthcare professionals. The symposium includes four plenary sessions, podium and poster sessions, and practice/research workshops, with web-based content delivery and integration of virtual content over five years to allow for greater reach. The areas of focus for the upcoming symposiums include off-label drug use during the COVID-19 pandemic, drug burden, safer opioid use, adverse drug events, significant drug interactions, drug safety during transitions of care, and medication safety in inpatient care. The target audience includes physicians, nurses, pharmacists, students, residents, fellows, researchers, and others. Educational and media tools will be created in addition to publishing the proceedings in the Research in Social and Administrative Pharmacy journal. Overall, the Geriatric Medication Safety Symposium will provide a unique interprofessional educational and research forum for practitioners and researchers to make medication practices safer for older adults in the TMC and beyond.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deprescribing of Disease Modifying Agents in Older Adults with Multiple Sclerosis
  • 批准号:
    10718559
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2023
  • 负责人:
    Rajender R Aparasu
  • 依托单位:
Oral Adherence Trajectories Of Disease Modifying Agents And Associated Relapse Rates Among Patients With Multiple Sclerosis
  • 批准号:
    10434699
  • 项目类别:
  • 资助金额:
    $2.58万
  • 财政年份:
    2021
  • 负责人:
    Rajender R Aparasu
  • 依托单位:
Geriatric Medication Safety Symposium
  • 批准号:
    10669108
  • 项目类别:
  • 资助金额:
    $5.0万
  • 财政年份:
    2021
  • 负责人:
    Rajender R Aparasu
  • 依托单位:
Geriatric Medication Safety Symposium
  • 批准号:
    10237632
  • 项目类别:
  • 资助金额:
    $5.0万
  • 财政年份:
    2021
  • 负责人:
    Rajender R Aparasu
  • 依托单位:
海外基金